PCR 分子診斷市場規模、佔有率、成長分析（按產品、應用、最終用戶和地區）- 產業預測，2025-2032 年

2023 年全球 PCR 分子診斷市場規模價值 82 億美元，預計將從 2024 年的 86.7 億美元成長到 2032 年的 135 億美元，預測期內（2025-2032 年）的複合年成長率為 5.7%。

全球 PCR 分子診斷市場正在經歷快速成長，這得益於對識別感染疾病、遺傳疾病和癌症所必需的準確、及時的診斷測試的需求不斷成長。 PCR 技術透過擴增和檢測特定的 DNA 或 RNA 序列來增強了診斷能力，從而實現了個人化的治療方法。然而，高成本、技術複雜性和監管障礙等挑戰可能會阻礙廣泛採用。然而，包括可攜式和照護現場設備在內的 PCR 技術的進步為市場擴張提供了巨大的機會。此外，PCR與次世代定序和數位健康平台的結合為多重檢測和客製化治療鋪平了道路。精準醫療意識的不斷增強進一步增強了改變醫療診斷和治療的市場潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

PCR 分子診斷市場規模（依產品分類）

• 市場概況
• 裝置
  • 標準 PCR 體系
  • 數位PCR系統
  • 即時PCR系統
• 試劑和耗材
• 軟體

PCR 分子診斷市場規模（按應用）

• 市場概況
• 傳染病檢查
• 腫瘤學檢測
• 其他用途

PCR 分子診斷市場規模（以最終用戶分類）

• 市場概況
• 醫院
• 診斷實驗室
• 其他

PCR分子診斷市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• F. Hoffmann-La Roche Ltd（Switzerland）
• Thermo Fisher Scientific Inc.（US）
• Abbott Laboratories（US）
• Qiagen NV（Netherlands）
• Bio-Rad Laboratories, Inc.（US）
• Agilent Technologies, Inc.（US）
• Danaher Corporation（US）
• Hologic, Inc.（US）
• Siemens Healthineers AG（Germany）
• PerkinElmer, Inc.（US）
• Becton, Dickinson and Company（US）
• bioMerieux SA（France）
• Meridian Bioscience, Inc.（US）
• QIAGEN Manchester Ltd（UK）
• Merck KGaA（Germany）

結論和建議

Global PCR Molecular Diagnostics Market size was valued at USD 8.2 billion in 2023 and is poised to grow from USD 8.67 billion in 2024 to USD 13.5 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global PCR molecular diagnostics market is witnessing rapid growth, fueled by the increasing demand for accurate and timely diagnostic testing essential for identifying infectious diseases, genetic disorders, and cancer. PCR technology enhances diagnostic capabilities through the amplification and detection of specific DNA or RNA sequences, enabling personalized treatment approaches. However, challenges like high costs, complexity of techniques, and regulatory hurdles may hinder widespread adoption. Yet, advancements in PCR technology, including portable instruments and point-of-care devices, present significant opportunities for market expansion. Additionally, integrating PCR with next-generation sequencing and digital health platforms paves the way for multiplex testing and tailored therapies. Growing awareness of precision medicine further bolsters the market's potential to transform healthcare diagnostics and treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pcr Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global PCR Molecular Diagnostics Market Segmental Analysis

Global PCR Molecular Diagnostics Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Instrument, Reagents and Consumables and Software. Based on Application, the market is segmented into Infectious Disease Testing, Oncology Testing and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global PCR Molecular Diagnostics Market

One of the key drivers of the global PCR molecular diagnostics market is the rising emphasis on precision medicine. This innovative approach prioritizes the customization of medical treatments to suit individual patients' genetic profiles. By identifying specific genetic variations and biomarkers linked to various diseases, PCR molecular diagnostics facilitate the development of personalized treatment strategies. As healthcare systems increasingly embrace precision medicine methodologies, the demand for PCR molecular diagnostics is projected to grow significantly, enhancing the capability of healthcare providers to deliver tailored therapeutic interventions by the year 2022 and beyond.

Restraints in the Global PCR Molecular Diagnostics Market

One of the primary constraints facing the global PCR molecular diagnostics market is the substantial cost associated with testing. This financial burden can be particularly challenging in resource-constrained environments and areas with limited healthcare funding. The expenses related to the necessary equipment, reagents, and the recruitment of skilled personnel for conducting PCR tests contribute to accessibility issues, which are especially pronounced in developing nations. These cost limitations can hinder the broader adoption and implementation of PCR molecular diagnostics, posing significant challenges to achieving widespread testing and diagnosis in various regions, particularly in 2022.

Market Trends of the Global PCR Molecular Diagnostics Market

The global PCR molecular diagnostics market is experiencing a significant trend towards the integration of PCR technology with digital health platforms and telehealth solutions. This convergence enhances patient access to diagnostic services through remote test ordering and result reporting, improving overall efficiency in healthcare delivery. As healthcare providers leverage telehealth for real-time monitoring and data management, the ability to track disease outbreaks and streamline diagnostic workflows becomes more attainable. This trend not only fosters patient convenience but also optimizes resource allocation in clinical settings, positioning the global PCR market for substantial growth as the demand for innovative and accessible healthcare solutions continues to rise.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global PCR Molecular Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instrument
  • Standard PCR Systems
  • Digital PCR Systems
  • Real-time PCR Systems
• Reagents and Consumables
• Software

Global PCR Molecular Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Other Applications

Global PCR Molecular Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Others

Global PCR Molecular Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN Manchester Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations